Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 28 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
NCT06997198
- Conditions
- Behavior, Behavioral Symptoms, Caregiver Burden, +15 more
- Locations
-
- University Hospitals of Cleveland Cleveland, Ohio, United States
Recruiting
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
NCT07365462
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Neurocrine Clinical Site Bryant, Arkansas, United States
- Neurocrine Clinical Site Chino, California, United States
- Neurocrine Clinical Site Fountain Valley, California, United States
- Neurocrine Clinical Site Huntington Beach, California, United States
- Conditions
- Bipolar Disorder, Bipolar and Related Disorders, Central Nervous System Diseases, +17 more
- Locations
-
- Neurocrine Clinical Site Bryant, Arkansas, United States
- Neurocrine Clinical Site Chino, California, United States
- Neurocrine Clinical Site Fountain Valley, California, United States
- Neurocrine Clinical Site Fresno, California, United States
NCT03495024
- Conditions
- Basal Ganglia Diseases, Behavior, Brain Diseases, +19 more
- Locations
-
- Corporal Michael J Crescenz VA Medical Center Philadelphia, Pennsylvania, United States
Not Yet Recruiting
Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients
NCT06218719
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Power Life Sciences San Francisco, California, United States
NCT02291861
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Teva Investigational Site 145 Tuscaloosa, Alabama, United States
- Teva Investigational Site 107 Anaheim, California, United States
- Teva Investigational Site 108 Anaheim, California, United States
- Teva Investigational Site 123 Glendale, California, United States
NCT05859698
- Conditions
- Bipolar Disorder, Bipolar and Related Disorders, Central Nervous System Diseases, +17 more
- Locations
-
- Neurocrine Clinical Site Bryant, Arkansas, United States
- Neurocrine Clinical Site Anaheim, California, United States
- Neurocrine Clinical Site Orange, California, United States
- Neurocrine Clinical Site Torrance, California, United States
Completed
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors
NCT04064294
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
- Locations
-
- VA Portland Health Care System, Portland, OR Portland, Oregon, United States
- Oregon Health & Science University Portland, Oregon, United States
- VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle, Washington, United States
NCT03287778
- Conditions
- Antipsychotic Agents, Central Nervous System Diseases, Dyskinesia, Drug-Induced, +10 more
- Locations
-
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
NCT02198794
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Teva Investigational Site 145 Tuscaloosa, Alabama, United States
- Teva Investigational Site 107 Anaheim, California, United States
- Teva Investigational Site 108 Anaheim, California, United States
- Teva Investigational Site 123 Glendale, California, United States
NCT02195700
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Tuscaloosa, Alabama, United States
- Anaheim, California, United States
- Glendale, California, United States
- Oceanside, California, United States
NCT03891862
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +7 more
- Locations
-
- Neurocrine Clinical Site Little Rock, Arkansas, United States
- Neurocrine Clinical Site Anaheim, California, United States
- Neurocrine Clinical Site Anaheim, California, United States
- Neurocrine Clinical Site Costa Mesa, California, United States
Completed
Pimavanserin Treatment in TS
NCT04794413
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Baylor College of Medicine Houston, Texas, United States
NCT01173731
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Indianapolis, Indiana, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia
NCT03698331
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +7 more
- Locations
-
- Neurocrine Clinical Site Anaheim, California, United States
- Neurocrine Clinical Site Glendale, California, United States
- Neurocrine Clinical Site Norwalk, California, United States
- Neurocrine Clinical Site Oceanside, California, United States
NCT02736955
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Anaheim, California, United States
- National City, California, United States
- Norwalk, California, United States
- Oakland, California, United States
NCT02405091
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Anaheim, California, United States
- Glendale, California, United States
- Irvine, California, United States
- Long Beach, California, United States
NCT02500628
- Conditions
- Central Nervous System Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +18 more
- Locations
-
- Woodinville Psychiatric Associates Woodinville, Washington, United States
Completed
Dysport for the Treatment of OMD
NCT01921270
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +8 more
- Locations
-
- Wesley Woods Health Center; Emory University Hospital Atlanta, Georgia, United States
NCT01688037
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Little Rock, Arkansas, United States
- Anaheim, California, United States
- Carson, California, United States
- Colton, California, United States